According to Zhitong Finance App, CLSA PREMIUM (06877) issued an announcement. The board of directors of the company expects the Group to obtain a consolidated net profit of about HK$7.7 million for the year ended 31 December 2023, and an audited net loss of about HK$31.1 million for the year ended 31 December 2022. The expected net profit is mainly due to a significant increase in the healthcare business in 2023, and the revenue from sales of health products more than tripled the 2022 revenue.
Furthermore, trading continues to be suspended.